Skip to main content
Premium Trial:

Request an Annual Quote

New Products: DNA Diagnostic Centre's Non-Invasive Prenatal Paternity Test


DNA Diagnostics Centre, a London-based DNA paternity and relationship testing firm, last week began advertising its DDC Non-Invasive Prenatal Paternity Test for UK residents, which relies on SNP microarray technology.

According to DDC, the test requires blood samples from both the mother and alleged father. The company did not name the test manufacturer in its statement or on its website. DDC said the array contains 317,000 genetic markers. DDC surveys the mother's blood for free-circulating fetal DNA in order to make a determination of paternity. The firm is marketing the test as an alternative to invasive tests that rely on samples provided via amniocentesis.

DDC is offering its test for £995 ($1,590) "plus collection fees."

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.